1. Home
  2. ATAI vs JMSB Comparison

ATAI vs JMSB Comparison

Compare ATAI & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • JMSB
  • Stock Information
  • Founded
  • ATAI 2018
  • JMSB 2005
  • Country
  • ATAI Germany
  • JMSB United States
  • Employees
  • ATAI N/A
  • JMSB N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • ATAI Health Care
  • JMSB Finance
  • Exchange
  • ATAI Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • ATAI 271.6M
  • JMSB 268.9M
  • IPO Year
  • ATAI 2021
  • JMSB N/A
  • Fundamental
  • Price
  • ATAI $1.40
  • JMSB $17.09
  • Analyst Decision
  • ATAI Strong Buy
  • JMSB
  • Analyst Count
  • ATAI 4
  • JMSB 0
  • Target Price
  • ATAI $9.00
  • JMSB N/A
  • AVG Volume (30 Days)
  • ATAI 2.1M
  • JMSB 19.0K
  • Earning Date
  • ATAI 03-17-2025
  • JMSB 04-24-2025
  • Dividend Yield
  • ATAI N/A
  • JMSB 1.41%
  • EPS Growth
  • ATAI N/A
  • JMSB 233.33
  • EPS
  • ATAI N/A
  • JMSB 1.20
  • Revenue
  • ATAI $308,000.00
  • JMSB $53,688,000.00
  • Revenue This Year
  • ATAI N/A
  • JMSB N/A
  • Revenue Next Year
  • ATAI $20.00
  • JMSB N/A
  • P/E Ratio
  • ATAI N/A
  • JMSB $14.56
  • Revenue Growth
  • ATAI N/A
  • JMSB 38.39
  • 52 Week Low
  • ATAI $0.78
  • JMSB $15.00
  • 52 Week High
  • ATAI $2.85
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 37.68
  • JMSB 35.75
  • Support Level
  • ATAI $1.33
  • JMSB $16.87
  • Resistance Level
  • ATAI $1.48
  • JMSB $17.84
  • Average True Range (ATR)
  • ATAI 0.10
  • JMSB 0.52
  • MACD
  • ATAI -0.02
  • JMSB 0.01
  • Stochastic Oscillator
  • ATAI 9.65
  • JMSB 17.44

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: